Friday, March 17, 2017

ACC: Novel PCSK9 Drug, Dropped for Risks, Was Effective in Trial

(MedPage Today) -- Problems with bococizumab appeared specific to that molecule
via ACC: Novel PCSK9 Drug, Dropped for Risks, Was Effective in Trial
by

No comments:

Post a Comment